How can we address the controversies surrounding the use of non-steroidal anti-inflammatory drugs in neurodegeneration?
In this editorial, we propose a novel approach to address the controversies of using non-steroidal anti-inflammatory drugs (NSAIDs) to prevent neurodegenerative disorders (NDD), such as Alzheimer’s disease, Parkinson’s disease, and Amyotrophic Lateral Sclerosis.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.